These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1725538)

  • 21. Renal protection with the calcium antagonists.
    Neumayer HH; Kunzendorf U
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction.
    Loutzenhiser R; Epstein M; Horton C; Sonke P
    J Pharmacol Exp Ther; 1985 Feb; 232(2):382-7. PubMed ID: 3968640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney.
    Loutzenhiser R; Epstein M; Horton C
    Am J Cardiol; 1987 Jan; 59(2):72A-75A. PubMed ID: 3812264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists and renal protection. Current status and future perspectives.
    Epstein M
    Arch Intern Med; 1992 Aug; 152(8):1573-84. PubMed ID: 1497390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of diltiazem and manganese renal hemodynamics: studies in the isolated perfused rat kidney.
    Loutzenhiser R; Horton C; Epstein M
    Nephron; 1985; 39(4):382-8. PubMed ID: 3982581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition.
    Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
    Transplantation; 1992 Dec; 54(6):1103-6. PubMed ID: 1465778
    [No Abstract]   [Full Text] [Related]  

  • 27. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T; Kanno Y; Hayashi K; Konishi K
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists in heart transplant recipients: effects on cardiac and renal function and cyclosporine pharmacokinetics.
    Legault L; Ogilvie RI; Cardella CJ; Leenen FH
    Can J Cardiol; 1993 Jun; 9(5):398-404. PubMed ID: 8348391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered renal microvascular response in Zucker obese rats.
    Hayashi K; Kanda T; Homma K; Tokuyama H; Okubo K; Takamatsu I; Tatematsu S; Kumagai H; Saruta T
    Metabolism; 2002 Dec; 51(12):1553-61. PubMed ID: 12489067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lovastatin has direct renal hemodynamic effects in a rodent model.
    Stowe NT; Inman SR; Tapolyai M; Brouhard BH; Hodge EE; Novick AC
    J Urol; 1996 Jul; 156(1):249-52. PubMed ID: 8648816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of pharmacologic kidney protection in preventing post-ischemic renal failure in animal experiment].
    Torsello G; Reinecke P; Szabo Z; Sandmann W
    Zentralbl Chir; 1993; 118(7):412-9. PubMed ID: 8372523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physiology and pathophysiology of renal circulation].
    Steinhausen M
    Z Kardiol; 1987; 76 Suppl 4():71-9. PubMed ID: 3442091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A; Christensen H; Hartmann A; Berg KJ
    Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrendipine and the pressure-dependent vasodilation of vessels in the hydronephrotic kidney.
    Steinhausen M; Fleming JT; Holz FG; Parekh N
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S39-43. PubMed ID: 2441183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists.
    Loutzenhiser R; Epstein M
    Am J Nephrol; 1987; 7 Suppl 1():7-16. PubMed ID: 3442293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
    Loutzenhiser R; Hayashi K; Epstein M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):522-8. PubMed ID: 2969977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal hemodynamic and natriuretic effects of atrial natriuretic factor.
    Maack T; Atlas SA; Camargo MJ; Cogan MG
    Fed Proc; 1986 Jun; 45(7):2128-32. PubMed ID: 3011521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydropyridine calcium antagonists and agonists in the isolated perfused Dahl rat kidney.
    Steele TH; Challoner-Hue L
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S44-8. PubMed ID: 2441184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney.
    Fleming JT; Parekh N; Steinhausen M
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1157-63. PubMed ID: 3425725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.